Baseline and longitudinal grey matter changes in newly diagnosed Parkinson’s disease: ICICLE-PD study

Mild cognitive impairment in Parkinson’s disease (PDMCI) is associated with progression to dementia in a majority of patients. Mak et al. reveal accelerated cortical thinning in patients with PDMCI compared to non-cognitively impaired patients and healthy controls. Patterns of cortical thinning may constitute biomarkers for increased dementia risk.

[1]  Houeto Jean-Luc.  [Parkinson's disease]. , 2022, La Revue du praticien.

[2]  R. Barker,et al.  Quality of life and mild cognitive impairment in early Parkinson's disease: does subtype matter? , 2015, Journal of Parkinson's disease.

[3]  John T. O'Brien,et al.  Progressive cortical thinning and subcortical atrophy in dementia with Lewy bodies and Alzheimer's disease , 2015, Neurobiology of Aging.

[4]  E. Tolosa,et al.  Structural MRI correlates of the MMSE and pentagon copying test in Parkinson's disease. , 2014, Parkinsonism & related disorders.

[5]  M. Dwyer,et al.  Subcortical Atrophy Is Associated with Cognitive Impairment in Mild Parkinson Disease: A Combined Investigation of Volumetric Changes, Cortical Thickness, and Vertex-Based Shape Analysis , 2014, American Journal of Neuroradiology.

[6]  E. Tolosa,et al.  Cortical thinning associated with mild cognitive impairment in Parkinson's disease , 2014, Movement disorders : official journal of the Movement Disorder Society.

[7]  David J. Brooks,et al.  Genetic impact on cognition and brain function in newly diagnosed Parkinson’s disease: ICICLE-PD study , 2014, Brain : a journal of neurology.

[8]  P. Svenningsson,et al.  Initial cognitive decline is associated with cortical thinning in early Parkinson disease , 2014, Neurology.

[9]  J. Kim,et al.  Subcortical grey matter changes in untreated, early stage Parkinson's disease without dementia. , 2014, Parkinsonism & related disorders.

[10]  O. Monchi,et al.  Mild cognitive impairment is linked with faster rate of cortical thinning in patients with Parkinson's disease longitudinally. , 2014, Brain : a journal of neurology.

[11]  T. Robbins,et al.  Characterizing mild cognitive impairment in incident Parkinson disease , 2014, Neurology.

[12]  Jose A. Obeso,et al.  Movement disorders—a growing journal for a growing field , 2014 .

[13]  O. Monchi,et al.  Mild cognitive impairment in patients with Parkinson's disease is associated with increased cortical degeneration , 2013, Movement disorders : official journal of the Movement Disorder Society.

[14]  Y. Sohn,et al.  Exploratory analysis of neuropsychological and neuroanatomical correlates of progressive mild cognitive impairment in Parkinson's disease , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[15]  O. Tysnes,et al.  Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study. , 2013, JAMA neurology.

[16]  Mojtaba Zarei,et al.  Cortical thinning is associated with disease stages and dementia in Parkinson's disease , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[17]  R. Monastero,et al.  The neuropsychiatric profile of Parkinson’s disease subjects with and without mild cognitive impairment , 2013, Journal of Neural Transmission.

[18]  J. Kulisevsky,et al.  Pattern of Regional Cortical Thinning Associated with Cognitive Deterioration in Parkinson’s Disease , 2013, PloS one.

[19]  R. Barker,et al.  The spectrum of nonmotor symptoms in early Parkinson disease , 2013, Neurology.

[20]  E. Tolosa,et al.  Progression of cortical thinning in early Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.

[21]  Nuria Bargallo,et al.  Assessment of cortical degeneration in patients with Parkinson's disease by voxel‐based morphometry, cortical folding, and cortical thickness , 2012, Human brain mapping.

[22]  Roger A. Barker,et al.  Cognitive Impairment in Parkinson's Disease: The Dual Syndrome Hypothesis , 2012, Neurodegenerative Diseases.

[23]  C. Tanner,et al.  Dopamine transporter imaging is associated with long‐term outcomes in Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.

[24]  Roger A. Barker,et al.  White matter pathology in Parkinson's disease: The effect of imaging protocol differences and relevance to executive function , 2012, NeuroImage.

[25]  Maria C. Rodriguez-Oroz,et al.  Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson’s disease , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[26]  Bruce Fischl,et al.  Within-subject template estimation for unbiased longitudinal image analysis , 2012, NeuroImage.

[27]  R. Barker,et al.  Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines , 2012, Movement disorders : official journal of the Movement Disorder Society.

[28]  O. Abe,et al.  Cognitive status correlates with white matter alteration in Parkinson's disease , 2012, Human brain mapping.

[29]  M. A. Buchem,et al.  Ventral striatal volume is associated with cognitive decline in older people: a population based MR-study , 2012, Neurobiology of Aging.

[30]  A. Formiconi,et al.  Interaction of caudate dopamine depletion and brain metabolic changes with cognitive dysfunction in early Parkinson's disease , 2012, Neurobiology of Aging.

[31]  P. Moberg,et al.  Neurodegeneration across stages of cognitive decline in Parkinson disease. , 2011, Archives of neurology.

[32]  T. Anderson,et al.  Grey matter atrophy in cognitively impaired Parkinson's disease , 2011, Journal of Neurology, Neurosurgery & Psychiatry.

[33]  C. Jack,et al.  Temporoparietal atrophy: A marker of AD pathology independent of clinical diagnosis , 2011, Neurobiology of Aging.

[34]  Bruce Fischl,et al.  Avoiding asymmetry-induced bias in longitudinal image processing , 2011, NeuroImage.

[35]  Dagmar Verbaan,et al.  The MoCA: Well-suited screen for cognitive impairment in Parkinson disease , 2011, Neurology.

[36]  Alan C. Evans,et al.  Patterns of cortical thickness and surface area in early Parkinson's disease , 2011, NeuroImage.

[37]  Chantal E Stern,et al.  Focal cortical and subcortical atrophy in early Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.

[38]  Hae-Jeong Park,et al.  The pattern of cortical atrophy in patients with Parkinson's disease according to cognitive status , 2011, Movement disorders : official journal of the Movement Disorder Society.

[39]  Bruce Fischl,et al.  Highly accurate inverse consistent registration: A robust approach , 2010, NeuroImage.

[40]  C. Clarke,et al.  Systematic review of levodopa dose equivalency reporting in Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.

[41]  Rachel L. Mistur,et al.  Subregional hippocampal atrophy predicts Alzheimer's dementia in the cognitively normal , 2010, Neurobiology of Aging.

[42]  Marios Politis,et al.  Serotonergic Neurons Mediate Dyskinesia Side Effects in Parkinson’s Patients with Neural Transplants , 2010, Science Translational Medicine.

[43]  R. Barker,et al.  The val158met COMT polymorphism's effect on atrophy in healthy aging and Parkinson's disease , 2010, Neurobiology of Aging.

[44]  Turi O. Dalaker,et al.  Gray matter correlations of cognition in incident Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.

[45]  Johannes C. Klein,et al.  Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo , 2010, Neurology.

[46]  Thomas Foltynie,et al.  The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. , 2009, Brain : a journal of neurology.

[47]  Jeffrey L. Birk,et al.  Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder. , 2009, The American journal of psychiatry.

[48]  S. Aalto,et al.  Impaired cognitive performance in Parkinson's disease is related to caudate dopaminergic hypofunction and hippocampal atrophy. , 2009, Parkinsonism & related disorders.

[49]  J. Nutt,et al.  The Unified Dyskinesia Rating Scale: Presentation and clinimetric profile , 2008, Movement disorders : official journal of the Movement Disorder Society.

[50]  T. Robbins,et al.  Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. , 2007, Brain : a journal of neurology.

[51]  S. Leh,et al.  Fronto-striatal connections in the human brain: A probabilistic diffusion tractography study , 2007, Neuroscience Letters.

[52]  C. Tanner,et al.  Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030 , 2007, Neurology.

[53]  Ayse Pinar Saygin,et al.  Smoothing and cluster thresholding for cortical surface-based group analysis of fMRI data , 2006, NeuroImage.

[54]  P. Calabresi,et al.  A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine–acetylcholine synaptic balance , 2006, The Lancet Neurology.

[55]  D. Aarsland,et al.  A magnetic resonance imaging study of patients with Parkinson’s disease with mild cognitive impairment and dementia using voxel-based morphometry , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[56]  I. McKeith,et al.  Brain atrophy rates in Parkinson's disease with and without dementia using serial magnetic resonance imaging , 2005, Movement disorders : official journal of the Movement Disorder Society.

[57]  D. Aarsland,et al.  Cognitive Predictors of Dementia in Parkinson’s Disease: A Community-Based, 4-Year Longitudinal Study , 2005, Journal of geriatric psychiatry and neurology.

[58]  A. Dale,et al.  Thinning of the cerebral cortex in aging. , 2004, Cerebral cortex.

[59]  I. McKeith,et al.  Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls. , 2004, Brain : a journal of neurology.

[60]  T. Robbins,et al.  The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study. , 2004, Brain : a journal of neurology.

[61]  H. Spiers,et al.  Prefrontal and medial temporal lobe interactions in long-term memory , 2003, Nature Reviews Neuroscience.

[62]  D. Aarsland,et al.  Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. , 2003, Archives of neurology.

[63]  Yoav Ben-Shlomo,et al.  The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. , 2002, Brain : a journal of neurology.

[64]  I. McKeith,et al.  Effects of Rivastigmine on Cognitive Function in Dementia with Lewy Bodies: A Randomised Placebo-Controlled International Study Using the Cognitive Drug Research Computerised Assessment System , 2002, Dementia and Geriatric Cognitive Disorders.

[65]  T. Goldberg,et al.  Dopaminergic modulation of cortical function in patients with Parkinson's disease , 2002, Annals of neurology.

[66]  A M Dale,et al.  Measuring the thickness of the human cerebral cortex from magnetic resonance images. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[67]  D. Aarsland,et al.  Mental symptoms in Parkinson's disease are important contributors to caregiver distress , 1999, International journal of geriatric psychiatry.

[68]  A. Dale,et al.  Cortical Surface-Based Analysis II: Inflation, Flattening, and a Surface-Based Coordinate System , 1999, NeuroImage.

[69]  Anders M. Dale,et al.  Cortical Surface-Based Analysis I. Segmentation and Surface Reconstruction , 1999, NeuroImage.

[70]  M. Hoehn,et al.  Parkinsonism , 1998, Neurology.

[71]  A. Lees,et al.  The relationship between dementia and direct involvement of the hippocampus and amygdala in Parkinson's disease , 1997, Neurology.

[72]  T. Robbins,et al.  CANTAB battery: proposed utility in neurotoxicology. , 1996, Neurotoxicology and teratology.

[73]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[74]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[75]  D. Aarsland,et al.  Prevalence and Characteristics of Dementia in Parkinson Disease , 2015 .

[76]  Amity E. Green,et al.  Mapping cortical atrophy in Parkinson's disease patients with dementia. , 2013, Journal of Parkinson's disease.

[77]  V. Leirer,et al.  Development and validation of a geriatric depression screening scale: a preliminary report. , 1982, Journal of psychiatric research.